Ceftriaxone NDC 72572-061

NDC codes

FDA NDC Directory

Product NDC (as listed)72572-061Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72572-0061Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72572-061-25	72572006125	25 VIAL in 1 BOX (72572-061-25) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL (72572-061-01)Marketed from Mar 1, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ceftriaxone
Generic name (nonproprietary): ceftriaxone
Active ingredients: Ceftriaxone sodium — 1 g/1
Dosage form: Injection, Powder, For solution
Route: Intramuscular, Intravenous
Labeler: Civica, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 065342
Marketing start: Mar 1, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Cephalosporins (Chemical structure)
Identifiers: Product ID 72572-061_36b74132-c90c-4cda-bd0c-93855b45e205SPL ID 36b74132-c90c-4cda-bd0c-93855b45e205SPL set ID 96f3fc1e-84f4-4e9b-91ac-19a1692f227aRxCUI 1665021, 1665046UNII 023Z5BR09K
Pharmacologic class: Cephalosporin Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeMed-Code curated

J0696 — Injection, ceftriaxone sodium, per 250 mg

Billing unit: 250 mg. Units on the claim = dose given ÷ 250 mg.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N472572006125 followed by a unit qualifier and the quantity

Package 72572-0061-25. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 6, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE Before instituting treatment with Ceftriaxone for Injection, USP, appropriate specimens should be obtained for isolation of the causative organism and for determination of its susceptibility to the drug. Therapy may be instituted prior to obtaining results of susceptibility testing. To reduce the development of drug-resistant bacteria and maintain the effectiveness of Ceftriaxone for Injection, USP and other antibacterial drugs, Ceftriaxone for Injection, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 065342

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 065342
Product	Strength	Form · route	Labeler	Product NDC
Ceftriaxone	Ceftriaxone sodium 2 g/1	Injection, Powder, For solutionIntramuscular, Intravenous	Hikma Pharmaceuticals USA Inc.	0143-9856
Ceftriaxone	Ceftriaxone sodium 1 g/1	Injection, Powder, For solutionIntramuscular, Intravenous	Hikma Pharmaceuticals USA Inc.	0143-9857
Ceftriaxone	Ceftriaxone sodium 500 mg/1	Injection, Powder, For solutionIntramuscular, Intravenous	Hikma Pharmaceuticals USA Inc.	0143-9858
Ceftriaxone	Ceftriaxone sodium 250 mg/1	Injection, Powder, For solutionIntramuscular, Intravenous	Hikma Pharmaceuticals USA Inc.	0143-9859
Ceftriaxone	Ceftriaxone sodium 2 g/1	Injection, Powder, For solutionIntramuscular, Intravenous	Civica, Inc.	72572-062